In a recent study, both lymphoblastoid cells from control patients bearing a high-risk allele of LRRK2 and dendritic cells from CD patients exhibited elevated LRRK2 expression, which resulted in severe colitis with increased Dectin-1-mediated NF-κB activation and proinflammatory cytokine responses [25]. Here, LRRK2 is linked to colitis.